Literature DB >> 2524476

Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family.

J F Tait1, D Gibson, K Fujikawa.   

Abstract

Human placental anticoagulant protein-I (PAP-I) is a member of the lipocortin/calpactin/annexin family of Ca2+-dependent phospholipid binding proteins. PAP-I was labeled with fluorescein 5-isothiocyanate (1 mol/mol); this derivative had anticoagulant activity identical to the unlabeled protein and could be used to measure Ca2+-dependent binding to phospholipid vesicles through changes in fluorescence quenching. At 1.2 mM Ca2+, 0.50 M ionic strength, pH 7.4, 25 degrees C, fluorescein-labeled PAP-I bound to phospholipid vesicles containing 80% phosphatidylcholine, 20% phosphatidylserine with a Kd of 1.2 +/- 0.2 nM (mean +/- S.D.). At an ionic strength of 0.15 M, the Kd decreased to less than 0.1 nM. Prothrombin and factor Xa both competed with fluorescein-labeled PAP-I for binding to anionic phospholipid vesicles, but with affinities at least 1000-fold weaker than PAP-I. PAP-I bound only weakly (Kd greater than 2 x 10(-5) M) to neutral or anionic phospholipid monomers, and this binding was not calcium-dependent. These results show that the affinity of PAP-I for anionic phospholipid surfaces is sufficient to explain its potency as an in vitro anticoagulant.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524476

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

Review 1.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

2.  Factor VIIa binding and internalization in hepatocytes.

Authors:  G Hjortoe; B B Sorensen; L C Petersen; L V M Rao
Journal:  J Thromb Haemost       Date:  2005-10       Impact factor: 5.824

3.  Enhancement of enveloped virus entry by phosphatidylserine.

Authors:  David A Coil; A Dusty Miller
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 4.  Annexins: calcium-binding proteins of multi-functional importance?

Authors:  J Römisch; E P Pâques
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

5.  Loss of membrane asymmetry alters the interactions of erythrocytes with engineered silica nanoparticles.

Authors:  Parnian Bigdelou; Amid Vahedi; Evangelia Kiosidou; Amir M Farnoud
Journal:  Biointerphases       Date:  2020-06-29       Impact factor: 2.456

Review 6.  Physiopathology of thrombosis induced by antiphospholipid antibodies.

Authors:  J M Zini
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

7.  Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.

Authors:  Xiao-Xuan Wu; Seth Guller; Jacob H Rand
Journal:  Am J Obstet Gynecol       Date:  2011-06-24       Impact factor: 8.661

8.  Induction of Eryptosis in Red Blood Cells Using a Calcium Ionophore.

Authors:  Parnian Bigdelou; Amir M Farnoud
Journal:  J Vis Exp       Date:  2020-01-21       Impact factor: 1.355

9.  18F-labelled annexin V: a PET tracer for apoptosis imaging.

Authors:  Yoshihiro Murakami; Hiroyuki Takamatsu; Junichi Taki; Mitsuyoshi Tatsumi; Akihiro Noda; Rikiya Ichise; Jonathan F Tait; Shintaro Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12-10       Impact factor: 9.236

10.  Transmembrane voltage regulates binding of annexin V and lactadherin to cells with exposed phosphatidylserine.

Authors:  Christina Smith; Donald F Gibson; Jonathan F Tait
Journal:  BMC Biochem       Date:  2009-02-17       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.